# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-017981
Filing Date
2023-11-07
Accepted
2023-11-07 16:02:38
Documents
66
Period of Report
2023-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | crvs-20230930x10q.htm iXBRL | 10-Q | 1929957
2 | EX-31.1 | crvs-20230930xex31d1.htm | EX-31.1 | 11899
3 | EX-31.2 | crvs-20230930xex31d2.htm | EX-31.2 | 11837
4 | EX-32.1 | crvs-20230930xex32d1.htm | EX-32.1 | 11818
| Complete submission text file | 0001558370-23-017981.txt |  | 6902257

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
5 | EX-101.SCH | crvs-20230930.xsd | EX-101.SCH | 41771
6 | EX-101.CAL | crvs-20230930_cal.xml | EX-101.CAL | 48575
7 | EX-101.DEF | crvs-20230930_def.xml | EX-101.DEF | 152350
8 | EX-101.LAB | crvs-20230930_lab.xml | EX-101.LAB | 368470
9 | EX-101.PRE | crvs-20230930_pre.xml | EX-101.PRE | 277109
60 | EXTRACTED XBRL INSTANCE DOCUMENT | crvs-20230930x10q_htm.xml | XML | 1158150

Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

EIN.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37719 | Film No.: 231383574
SIC: 2834 Pharmaceutical Preparations